VBL Therapeutics to Report Second Quarter 2019 Financial Results on August 13

by NASDAQ Market News August 5, 2019

NASDAQ Market News
Click here to email author

SELLAS Announces Completion of Enrollment in Randomized Phase 2 VADIS Trial of Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast

Influenza Diagnostic Tests Market to hit $1.5 billion by 2025: Global Market Insights, Inc.

Ads